Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Depreciation & Amortization (CF): 2015-2025

Historic Depreciation & Amortization (CF) for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $1.3 million.

  • AC Immune's Depreciation & Amortization (CF) rose 221.00% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 435.25%. This contributed to the annual value of $1.7 million for FY2024, which is 10.07% down from last year.
  • According to the latest figures from Q3 2025, AC Immune's Depreciation & Amortization (CF) is $1.3 million, which was up 203.35% from $438,464 recorded in Q2 2025.
  • AC Immune's Depreciation & Amortization (CF)'s 5-year high stood at $1.3 million during Q3 2025, with a 5-year trough of -$1.4 million in Q3 2022.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $438,464 (2025), whereas its average is $278,580.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 355.64% in 2022, then spiked by 221.00% in 2025.
  • AC Immune's Depreciation & Amortization (CF) (Quarterly) stood at $527,068 in 2021, then fell by 9.01% to $479,566 in 2022, then fell by 1.97% to $470,107 in 2023, then fell by 12.83% to $409,806 in 2024, then surged by 221.00% to $1.3 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.3 million for Q3 2025, versus $438,464 for Q2 2025 and $401,522 for Q1 2025.